Karachi Paper | EnglishKarachi Paper | English
Font ResizerAa
  • Home
  • Banks
  • IPPs
  • Courts
  • Health
  • Education
  • Pakistan
  • World
  • Local Bodies
  • Aviation
  • FBR
  • NGOs
  • Scholarship
  • Palestine/IsraelNew
  • Middle EastNew
  • اردو
Reading: Revelation of Manufacturing and Supply of Spurious International Brand Medicines in Pakistan
Share
Karachi Paper | EnglishKarachi Paper | English
Font ResizerAa
Search
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Karachi Paper | English > Blog > Health > Revelation of Manufacturing and Supply of Spurious International Brand Medicines in Pakistan
HealthLatest

Revelation of Manufacturing and Supply of Spurious International Brand Medicines in Pakistan

Karachi Papers
Last updated: January 21, 2025 9:08 pm
Karachi Papers
Share
SHARE

The sale and use of two batches of counterfeit medicines have been banned following the revelation that spurious international brand medicines are being manufactured and sold across Pakistan.

According to the Drug Regulatory Authority of Pakistan (DRAP), counterfeit drugs intended for anesthesia and for the treatment of multiple sclerosis were distributed in multiple cities across Pakistan.

The forged medicine packaging featured addresses from French and German manufacturing companies. The Drug Testing Lab Punjab has confirmed that samples of both drugs were found to be counterfeit.

As per the DRAP Recall Alert, Batch No.20158 of Ketamine Injection 500 mg, used for anesthesia, was declared spurious. The injection packet bears the address of Pan Pharma France.

Additionally, a counterfeit batch of 300 mg Ocrevus Solution for Injection, used in the treatment of multiple sclerosis, was distributed under Batch No. H0041B27.

This fake product, which carries the address of Roche Diagnostics Germany, was reported by the pharmaceutical company Roche Pakistan. DRAP has released images of the counterfeit Ocrevus solution.

After investigation, Roche Global confirmed that the product available in Pakistan was spurious. Investigations revealed that the original Ocrevus, Batch No. H0041B, was supplied in Turkey in August 2020 with an expiry date of February 7, 2022. In contrast, the counterfeit product bears an expiry date of September 5, 2025.

In response, DRAP has instructed its regulatory field force to heighten vigilance across the supply chain to seize said counterfeit products. The alert has directed pharmacists, chemists, and healthcare professionals to immediately check their stocks and notify the regulatory field force, provincial health departments, and authorities about the suppliers of these products.

The alert also called on provincial governments to implement additional measures to prevent the spread of fake medicines and has urged the Punjab government to conduct a thorough investigation into the counterfeit medicine supply chain.

You Might Also Like

Despite 10 Months, Sarim Burney yet to be indicted in human trafficking case, 3 proclaimed offenders still at large

Kabul: Minister for Public works calls on Chinese Ambassador to Discuss Key Projects

New Gwadar International Airport Set to Operational on January 20

SHC Rejects Daewoo Pakistan Consortium’s Plea in Islamabad Airport Outsourcing Case

Stray Dogs posse Growing Threat to Flight Operations at Karachi Airport

Share This Article
Email Copy Link Print
Previous Article Financial Control Rift Between AG Sindh and Additional AG Escalates to Bilawal House
Next Article Drought Warning Issued Amidst Low Rainfall Across Pakistan
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Revelations of massive external pressure behind FBR posting preferences, officers, officials using influence for field postings
    Questions mount as suspended customs officer reinstated after seeking Finance Minister’s recommendation for "Choice Posting"
  • Despite 10 Months, Sarim Burney yet to be indicted in human trafficking case, 3 proclaimed offenders still at large
  • PIA Privatization Talks Intensify, Buyers Demand Govt to Clear Rs.152 billion Liabilities
  • Afghanistan Accuses UN Mission of Spreading Negative Propaganda Against Country
  • Criminal Negligence by DRAP Leads to Widespread Distribution of Spurious Drugs in Country
    Multinational Giants like Sanofi, GSK, and Roche Among Companies Manufacturing Substandard Drugs

Recent Comments

No comments to show.

You Might Also Like

LatestWorld

Islamic Emirate of Afghanistan Rejects ICC Jurisdiction, Citing Political Bias
Kabul accuses International Criminal Court of prioritizing political ambitions over justice

The Islamic Emirate of Afghanistan has criticized the International Criminal Court (ICC), calling it against Afghanistan's sovereignty. According to the…

2 Min Read
HealthLatest

Sind: Tumbling Health System, Thousands Affected by Deadly Diseases in 2024

In 2024, because of inadequate health facilities the citizens of Sindh province faced a relentless menace of epidemic diseases caused…

2 Min Read
LatestWorld

Kabul: Government Allocates 1 Billion AFS For Drug Addicts Treatment

Since the Taliban took power, one of the significant challenges faced by the government has been the pervasive drug problem…

3 Min Read
LatestWorld

Afghanistan Inked $500,000 MoU with AAR Japan to Combat Landmines Threat

An agreement worth $52,296 has been signed between Afghanistan's National Disaster Management and Association for Aid and Relief (AAR) Japan…

2 Min Read
Karachi Paper | EnglishKarachi Paper | English
© 2025 Karachi Papers Network. All Rights Reserved
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?